Vanda Pharmaceuticals Inc. (VNDA) Social Stream
VANDA PHARMACEUTICALS INC (VNDA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering VANDA PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 2 | $24 | $22 | $23 | $6.37 | 261.07% |
| 2021-11-23 | 3 | $24 | $14 | $20.666 | $6.37 | 224.43% |
| 2022-02-04 | 2 | $24 | $20 | $22 | $6.37 | 245.37% |
| 2022-02-25 | 2 | $16 | $12 | $14 | $6.37 | 119.78% |
| 2022-04-24 | 1 | $12 | $12 | $12 | $6.37 | 88.38% |
| 2022-08-03 | 1 | $10 | $10 | $10 | $6.37 | 56.99% |
| 2022-11-03 | 1 | $11 | $11 | $11 | $6.37 | 72.68% |
| 2023-02-10 | 1 | $7 | $7 | $7 | $6.37 | 9.89% |
The Trend in the Analyst Price Target
VNDA's average price target has moved down $16 over the prior 15 months.
VNDA reports an average of 3.04% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-27 | 1 | 12 | 12 | 12 | 11.46 | 4.71% |
| 2022-05-06 | 1 | 10 | 10 | 10 | 9.60 | 4.17% |
| 2022-08-03 | 1 | 10 | 10 | 10 | 10.80 | -7.41% |
| 2022-11-03 | 1 | 11 | 11 | 11 | 10.13 | 8.59% |
| 2023-02-10 | 1 | 7 | 7 | 7 | 7.27 | -3.71% |
VNDA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 1 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 28 months, VNDA's average broker recommendation rating worsened by 1.33.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, VANDA PHARMACEUTICALS INC's number of analysts covering the stock is higher than 33.69% of them.
- VNDA has a lower variance in analysts' estimates than -4.99% of Pharmaceutical Products stocks.
- VNDA has a higher average analyst price target than 357.75% of Healthcare stocks.
- VANDA PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 632.05% of stocks in the small market cap category.
In the Pharmaceutical Products industry, ALT, HGEN, and OMER are the three stocks most similar to VANDA PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for VNDA? Use POWR Ratings for clearer insight into price direction.